Nanox (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is intended to expand Nanox AI’s commercial presence in the Italian market by leveraging Technologic’s experience and local market knowledge, according to a press release.
HealthOST analyzes eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis. The technology is part of Nanox’s broader ecosystem, which combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.
The distribution agreement matters because it represents a step in Nanox’s strategy to drive the world’s transition to preventive health care. By integrating AI into routine imaging workflows, Nanox aims to support early detection of disease and improve patient outcomes. Osteoporosis, a condition characterized by weakened bones and increased fracture risk, often goes undiagnosed until a fracture occurs. Tools like HealthOST that can flag at-risk patients from existing CT scans could enable earlier intervention and better management of the disease.
For Nanox, the deal with Technologic provides a local partner with market knowledge to navigate the Italian healthcare landscape. Technologic’s affiliation with Tecnologie Avanzate may offer additional credibility and reach. The agreement is intended to expand Nanox AI’s commercial presence in Italy, though the company did not disclose financial terms or expected timing for commercialization.
Nanox’s vision extends beyond traditional hospital settings. The company’s ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging; Nanox.CLOUD, a cloud-based platform for secure data management and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts; and Nanox Health IT, which delivers RIS, PACS, AI, dictation, and secure infrastructure solutions. By integrating these components, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
Investors can find more information about Nanox in the company’s newsroom at https://ibn.fm/NNOX. The full press release is available at https://ibn.fm/y9Zro, and terms of use and disclaimers applicable to content provided by IBN are available at https://IBN.ai/Disclaimer.
